Search

Your search keyword '"Matsushita, Takuya"' showing total 574 results

Search Constraints

Start Over You searched for: Author "Matsushita, Takuya" Remove constraint Author: "Matsushita, Takuya"
574 results on '"Matsushita, Takuya"'

Search Results

1. Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy

4. Forensic‐geology‐based magnetic analysis of beach sediments from the Shimokita Peninsula, Japan.

6. Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

7. A Retrospective Cohort Study of a Newly Proposed Criteria for Sporadic Creutzfeldt–Jakob Disease.

8. Effective efgartigimod treatment for severe thymoma‐associated myasthenia gravis experiencing myasthenic crisis: A case report.

10. Improvement in gait velocity variability after cerebrospinal fluid elimination and its relationship to clinical symptoms in patients with idiopathic normal pressure hydrocephalus

12. Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.

17. An ImmunoChip study of multiple sclerosis risk in African Americans.

19. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

20. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

21. Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis

25. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

29. NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk

31. The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1

34. Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis

36. Three‐dimensional magnetic resonance imaging of Baló‐like concentric lesion in multiple sclerosis.

41. Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy

Catalog

Books, media, physical & digital resources